Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood test may predict lung cancer drug success

NCT ID NCT04223596

Ongoing Disease control Sponsor: Fundación GECP Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a blood test (liquid biopsy) can help doctors see how well the drug brigatinib is working in people with a certain type of advanced lung cancer (ALK-positive NSCLC). About 33 patients who have not had chemotherapy before will take brigatinib pills daily. The main goal is to see how many patients' tumors shrink, and the blood test may help track changes over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER NSCLC NSCLC STAGE IIIB NSCLC STAGE IV

Contacts and locations

Locations

  • Complejo Hospitalario de A Coruña

    A Coruña, A Coruña, 15006, Spain

  • Hospital Clínico de Salamanca

    Salamanca, Salamanca, 37007, Spain

  • Hospital General de Alicante

    Alicante, Alicante, 03010, Spain

  • Hospital General de Valencia

    Valencia, Valencia, 46014, Spain

  • Hospital Puerta de Hierro

    Madrid, Madrid, 28222, Spain

  • Hospital Regional Universitario de Málaga

    Málaga, Andalusia, 29010, Spain

  • Hospital Son Espases

    Palma de Mallorca, Balearic Islands, 07120, Spain

  • Hospital Universitari i Politécnic La Fe

    Valencia, Valencia, 46009, Spain

  • Hospital Universitario Fundación Jiménez Díaz

    Madrid, Madrid, 28040, Spain

  • Hospital Universitario Insular de Gran canaria

    Las Palmas de Gran Canaria, Gran Canaria, 35016, Spain

  • Hospital Universitario de Cruces

    Barakaldo, Vizcaya, 48903, Spain

  • Hospital Vall Hebron

    Barcelona, 08035, Spain

  • Hospital de la Santa Creu i Sant Pau

    Barcelona, Catalonia, 08041, Spain

  • ICO Badalona

    Badalona, Barcelona, 08916, Spain

  • ICO Hospitalet

    L'Hospitalet de Llobregat, Barcelona, 08908, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.